There are outstanding changes not yet made by the legislation.gov.uk editorial team to The Cosmetic Products (Safety) Regulations 2004. Any changes that have already been made by the team appear in the content and are referenced with annotations.
Commencement Information
I1Sch. 7 Pt. 1 in force at 11.9.2004 in so far as commenced by inducing reg. 5(2), see reg. 1(1)
I2Sch. 7 Pt. 1 in force at 11.3.2005 in so far as commenced by inducing reg. 7(2)(9), see reg. 1(2)
| (1) | (2) | (3) | (4) | (5) |
|---|---|---|---|---|
| Reference Number | Name of substance | Maximum concentration of substance in product | Other requirements | Required information |
| 1 | 4-Aminobenzoic acid [PABA] | 5 per cent | — | — |
| 2 | N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl)anilinium methyl sulphate [Camphor benzalkonium methosulfate] | 6 per cent | — | — |
| 3 | Homosalate (INN) | 10 per cent | — | — |
| 4 | Oxybenzone (INN) [Benzophenone-3] | 10 per cent | — | Contains oxybenzone. (Not required when concentration is not more than 0.5 per cent, and when the substance is only intended to protect the product) |
| 5 | ENTRY DELETED | |||
| 6 | 2-Phenylbenzimidazole-5-sulphonic acid [Phenylbenzimidazole sulfonic acid] and its potassium, sodium and triethanolamine salts | 8 per cent (expressed as acid) | — | — |
| 7 | 3,3-(1,4-Phenylenedimethylene)bis(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-ylmethanesulfonic acid) [Terephthalylidene dicamphor sulfonic acid] and its salts | 10 per cent (expressed as acid) | — | — |
| 8 | 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)-propane-1,3-dione (Avobenzone (INN)) [Butyl methoxy dibenzoylmethane] | 5 per cent | — | — |
| 9 | α-(2-Oxoborn-3-ylidine)toluene-4-sulphonic acid [Benzylidene camphor sulfonic acid] and its salts | 6 per cent (expressed as acid) | — | — |
| 10 | 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate [Octocrylene] | 10 per cent (expressed as acid) | — | — |
| 11 | Polymer of N-[(2 and 4)-[2-oxoborn-3-ylidene)methyl]benzyl]acrylamide Polyacrylamidomethyl benzylidene camphor] | 6 per cent | — | — |
| 12 | 2-Ethylhexyl 4-methoxycinnamate [Octyl methoxycinnamate] | 10 per cent | — | — |
| 13 | Ethoxylated ethyl-4-aminobenzoate [PEG-25 PABA] | 10 per cent | — | — |
| 14 | Isopentyl 4-methoxycinnamate [Isoamyl p-methoxycinnamate] | 10 per cent | — | — |
| 15 | Tris(2-ethylhexyl) 4,4’4”-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate [Octyl triazone] | 5 per cent | — | — |
| 16 | 2-(2H-Benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-l-(trimethylsilyloxy)-disiloxan-1-yl]propyl]phenol [Drometrizole trisiloxane] | 15 per cent | — | — |
| 17 | Bis(2-ethylhexyl) 4,4’-[6-tert-butylcarbamoylanilino)-1,3,5-triazine-2,4-diyldiimino]dibenzoate | 10 per cent | — | — |
| 18 | 3-(4-Methylbenzylidine)bornan-2-one [4-Methylbenzylidene camphor] | 4 per cent | — | — |
| 19 | 3-Benzylodenebornan-2-one [3-Benzylidene camphor | 2 per cent | — | — |
| 20 | 2-Ethylhexyl salicylate [Octyl salicylate] | 5 per cent | — | — |
| 21 | 2-Ethylhexyl 4-dimethylaminobenzoate [Octyl dimethyl PABA] | 8 per cent | — | — |
| 22 | 2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid [Benzophenone-4] and its sodium salt [Benzophenone-5] (Sulisobenzone (INN) and Sulisobenzone sodium (INNM)) | 5 per cent (expressed as acid) | — | — |
| 23 | 2-2’-Methylenebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol] | 10 per cent | — | — |
| 24 | diSodium 2,2’-(1,4-phenylene)bis(lH-benzimidazole-4,6-disulfonate) | 10 per cent (expressed as acid) | — | — |
| 25 | 5,5’-Bis(2-ethylhexyloxy)-2,2’-(6-p-methoxyphenyl-1,3,5-triazine-2, 4-diyl)diphenol | 10 per cent | — | — |
| 26 | α-(Trimethylsilyl)-w-(trimethylsilyloxy)poly-[oxy(dimethyl)silylene]-co-[oxy(methyl)(2-[p-[2,2-bis(ethoxycarbonyl)vinyl]phenoxy]-1-methyleneethyl)silylene]-co-[oxy(methyl)(2-[p-[2,2-bis(ethoxycarbonyl)vinyl)]phenoxy]prop-1-enyl)silylene] where there are usually 60 polymeric units, of which the first part of the copolymer provides 56 (Dimethicodiethylbenzyalmalonate) (CAS No. 207574-74-1) | 10 per cent | — | — |
| 27 | Titanium dioxide | 25 per cent | — | — |
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
